ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER 2021 FINANCIAL RESULTS Plymouth Meeting, PA

ADAPTHEALTH CORP. ANNOUNCES FIRST QUARTER

2021 FINANCIAL RESULTS

Meeting, PA - May 6, 2021 - AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"),

a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies and related

services, announced today financial results for the first quarter ended March 31, 2021.

First Quarter Results

While it remains difficult to predict the duration and impact of the

COVID-19 crisis, based on current business and market trends, the Company is increasing its previously issued financial guidance for fiscal

year 2021 as follows:

Management Commentary

Steve Griggs, Co-CEO of AdaptHealth, commented, "I'm very

pleased with our Q1 2021 financial performance, which reflects the continued dedication and focus of our 9,331 employees who have worked

under extremely challenging circumstances over the past 12 months. Our financial results also reflect the hard work done by the AdaptHealth

and AeroCare teams to complete the acquisition of AeroCare and combine the operations of both companies while not missing a beat with

our patients, referring physicians and health systems. These efforts, combined with our strong organic growth for the quarter and the

continued strength of our M&A pipeline, are the reasons we remain excited about the outlook of our business."

Mr. Griggs continued, "In April, we closed the

acquisition of Spiro Health Services, a provider of home medical equipment and supplies, which substantially expands our presence

throughout New England and the Mid-Atlantic states and provides opportunities for both revenue and cost synergies. The Spiro Health

acquisition, like our acquisition of the Allina Health Home business in Minnesota, demonstrates our ability to expand our footprint

in growing markets through strategic acquisitions of market leaders."

Josh Parnes, President of AdaptHealth, commented, "We

are continuing to integrate and optimize technology across our organization to improve efficiencies, enhance sales and increase

customer satisfaction. This includes advancing the use of our e-prescribe platform, especially in our growing diabetes product line.

We are also very excited about the progress of our digital connected patient experience, where new technology product introductions

will help deliver solutions that bring us closer to our patients while improving outcomes and lowering costs."

Management will host a conference at 8:30 am ET

today to discuss the results and business activities. Interested parties may participate in the call by dialing:

423-9820 (Domestic) or

(201) 493-6749 (International)

registration: Click Here

the live call, a replay will be available for six months on the Company's website, www.adapthealth.com under "Investor

About AdaptHealth Corp.

is a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies,

and related services. AdaptHealth provides a full suite of medical products and solutions designed to help patients manage chronic conditions

in the home, adapt to life and thrive. Product and services offerings include (i) sleep therapy equipment, supplies and related

services (including CPAP and bi PAP services) to individuals suffering from obstructive sleep apnea, (ii) medical devices and supplies

to patients for the treatment of diabetes (including continuous glucose monitors and insulin pumps), (iii) home medical equipment

(HME) to patients discharged from acute care and other facilities, (iv) oxygen and related chronic therapy services in the home,

and (v) other HME medical devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence,

ostomy and nutritional supply needs. The Company is proud to partner with an extensive and highly diversified network of referral sources,

including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. AdaptHealth services beneficiaries

of Medicare, Medicaid and commercial insurance payors. AdaptHealth services approximately 3 million patients annually in all 50 states through

its network of 614 locations in 47 states. Learn more at www.adapthealth.com.

Forward-Looking Statements

This press release includes certain statements that are not historical

facts but are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation

Reform Act of 1995. Forward-looking statements generally are accompanied by words such as "believe," "may," "will,"

"estimate," "continue," "anticipate," "intend," "expect," "should,"

"would," "plan," "predict," "potential," "seem," "seek," "future,"

"outlook," and similar expressions that predict or indicate future events or trends or that are not statements of historical

matters. These forward-looking statements include, but are not limited to, statements regarding projections, estimates and forecasts of

revenue and other financial and performance metrics and projections of market opportunity and expectations and the Company's acquisition

pipeline. These statements are based on various assumptions and on the current expectations of AdaptHealth management and are not predictions

of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as,

and must not be relied on, by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability.

Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances

are beyond the control of the Company.

These forward-looking statements are subject to a number of risks and

uncertainties, including the outcome of judicial and administrative proceedings to which the Company may become a party or governmental

investigations to which the Company may become subject that could interrupt or limit the Company's operations, result in adverse

judgments, settlements or fines and create negative publicity; changes in the Company's clients' preferences, prospects and

the competitive conditions prevailing in the healthcare sector; and the impact of the recent coronavirus (COVID-19) pandemic and the Company's

response to it. A further description of such risks and uncertainties can be found in the Company's filings with the Securities

and Exchange Commission. If the risks materialize or assumptions prove incorrect, actual results could differ materially from the results

implied by these forward-looking statements. There may be additional risks that the Company presently knows or that the Company currently

believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition,

forward-looking statements reflect the Company's expectations, plans or forecasts of future events and views as of the date of this

press release. The Company anticipates that subsequent events and developments will cause the Company's assessments to change. However,

while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims

any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's assessments as

of any date subsequent to the date of this press release. Accordingly, undue reliance should not be placed upon the forward-looking statements.

Use of Non-GAAP Financial Information and Financial Guidance

This release contains non-GAAP financial guidance, which is adjusted

to exclude certain costs, expenses, gains and losses and other specified items that are evaluated on an individual basis. These non-GAAP

items are adjusted after considering their quantitative and qualitative aspects and typically have one or more of the following characteristics,

such as being highly variable, difficult to project, unusual in nature, significant to the results of a particular period or not indicative

of future operating results. Similar charges or gains were recognized in prior periods and will likely reoccur in future periods.

The Company uses EBITDA, Adjusted EBITDA and Adjusted EBITDA less Patient

Equipment Capex, which are financial measures that are not prepared in accordance with generally accepted accounting principles in the

United States, or U.S. GAAP, to analyze its financial results and believes that they are useful to investors, as a supplement to U.S.

GAAP measures. In addition, the Company's ability to incur additional indebtedness and make investments under its existing credit

agreement is governed, in part, by its ability to satisfy tests based on a variation of Adjusted EBITDA less Patient Equipment Capex.

The Company believes Adjusted EBITDA less Patient Equipment Capex is

useful to investors in evaluating the Company's financial performance. The Company's business requires significant investment

in equipment purchases to maintain its patient equipment inventory. Some equipment title transfers to patients' ownership after

a prescribed number of fixed monthly payments. Equipment that does not transfer wears out or often times is not recovered after a patient's

use of the equipment terminates. The Company uses this metric as the profitability measure in its incentive compensation plans that have

a profitability component and to evaluate acquisition opportunities, where it is most often used for purposes of contingent consideration

arrangements. In addition, the Company's debt agreements contain covenants that use a variation of Adjusted EBITDA less Patient

Equipment Capex for purposes of determining debt covenant compliance. For purposes of this metric, patient equipment capital expenditure

is measured as the value of the patient equipment received during the accounting period without regard to whether the equipment is purchased

or financed through lease transactions.

EBITDA, Adjusted EBITDA and Adjusted EBITDA less Patient Equipment

Capex should not be considered as measures of financial performance under U.S. GAAP, and the items excluded from EBITDA, Adjusted EBITDA

and Adjusted EBITDA less Patient Equipment Capex are significant components in understanding and assessing financial performance. Accordingly,

these key business metrics have limitations as an analytical tool. They should not be considered as an alternative to net income or any

other performance measures derived in accordance with U.S. GAAP or as an alternative to cash flows from operating activities as a measure

of the Company's liquidity.